On May 27, 2026, the Taiwan Food and Drug Administration (TFDA) announced that the Cosmetic Good Manufacturing Practice (GMP) standards will enter their third and final phase on July 1, 2026. From that date, all cosmetic manufacturing sites in Taiwan (excluding specified exempt cases) must comply with GMP requirements, marking a comprehensive upgrade in quality management across the Taiwanese cosmetics industry.
Policy Background
Taiwan, China amended the Cosmetics Hygiene and Safety Management Act in 2018 and established cosmetic GMP standards in alignment with international standards (ISO 22716). To allow the industry sufficient time for transition, a three-phase implementation schedule was designed with a 5-year buffer period. During the rollout, TFDA collaborated with industry, government, and academic sectors, conducting 111 GMP training sessions and 1,003 on-site guidance visits to assist manufacturers in establishing GMP-compliant internal control mechanisms.
Three-Phase Implementation Schedule
Phase 1 (July 1, 2024)
Covered manufacturing sites for specific-purpose cosmetics, including sunscreen, hair dye, hair perm, antiperspirant/deodorant, and at-home teeth whitening products.
Phase 2 (July 1, 2025)
Expanded to include manufacturing sites for infant-use, lip-use, eye-use cosmetics, as well as non-therapeutic toothpaste and mouthwash.
Phase 3 (July 1, 2026)
Covers all remaining general cosmetic manufacturing sites (excluding solid handmade soap manufacturers exempt from factory registration). Approximately 1,000 cosmetic manufacturing sites across Taiwan will be subject to GMP requirements.
GMP Regulatory Scope
Cosmetic GMP embodies the practical implementation of quality assurance principles, covering personnel, premises, facilities, equipment, raw materials, packaging materials, manufacturing operations, quality control, and documentation. GMP-compliant manufacturing sites must maintain Product Information Files (PIFs) that specify ingredient compositions and quantities, with clear Standard Operating Procedures (SOPs) and detailed records for every step — from raw material weighing, feeding, and mixing to filling, packaging, and finished product testing.
Government Support Measures
To facilitate industry adoption of GMP-compliant internal control processes, TFDA has continuously organized seminars, workshops, and on-site guidance programs. Manufacturers have been provided with self-assessment checklists and 26 key document templates. Going forward, TFDA will work with local health authorities to conduct ongoing inspections and guidance activities, monitoring implementation progress to ensure steady compliance across the industry.
CIRS Reminder
Taiwan, China's three-phase cosmetic GMP implementation will reach full coverage on July 1, 2026, at which point all cosmetic manufacturing sites must comply with GMP requirements (except solid handmade soap manufacturers). Companies with manufacturing facilities in Taiwan or sourcing from Taiwanese contract manufacturers are advised to verify GMP readiness as early as possible to avoid supply chain disruptions. Exporters to the Taiwanese market should also assess the impact of GMP requirements on product source compliance.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Our Services
- Taiwan Cosmetics Product Notification
- Taiwan Cosmetics PIF Documentation
- Taiwan Cosmetics Label Review
- Safety Assessment Report Preparation
- Cosmetics Safety and Efficacy Tests
Further Information：
TFDA
